Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Kelly Coffey.

Newcastle AuthorsTitleYearFull text
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2024
Zainab Alebady
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Emma Lishman-Walker
Jesslyn Choo
et al.
CDC20 is regulated by the histone methyltransferase, KMT5A, in castration resistant prostate cancer2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2023
Dr Kelly Coffey
Targeting the Hippo pathway in prostate cancer: What’s new?2021
Alex Bainbridge
Dr Scott Walker
Joseph Smith
Yi Min Ng Ng
Huw Thomas
et al.
IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway2020
Dr Frida Ponthan
Professor Olaf Heidenreich
Dr Kelly Coffey
Gene Silencing by RNAi in Mammalian Cells2015
Dr Mark Wade
Dominic Jones
Laura Wilson
Dr Jacqueline Stockley
Dr Kelly Coffey
et al.
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer2015
Dr Urszula McClurg
Victoria Harle
Dr Scott Walker
Dr Kelly Coffey
Dr Luke Gaughan
et al.
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer2015
Dr Urszula McClurg
Victoria Harle
Dr Kelly Coffey
Dr Steven Darby
Hollie Ramsey
et al.
Usp12 a novel AR co-regulator and PCa biomarker?2014
Dr Urszula McClurg
Victoria Harle
Dr Kelly Coffey
Dr Steven Darby
Hollie Ramsey
et al.
Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor2013
Dr Luke Gaughan
Dr Kelly Coffey
Dr Mark Wade
Sandy Tse
KDM4B is a Master Regulator of the Estrogen Receptor Signalling Cascade2013
Dr Kelly Coffey
Lynsey Rogerson
Claudia Ryan-Munden
Dhuha Alkharaif
Dr Jacqueline Stockley
et al.
The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover2013
Dr Kelly Coffey
Dr Tim Blackburn
Susan Cook
Emeritus Professor Bernard Golding
Professor Roger Griffin
et al.
Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer2012
Dr Stuart Williamson
Dr Anastasia Hepburn
Laura Wilson
Dr Kelly Coffey
Claudia Ryan-Munden
et al.
Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor2012
Dr Kelly Coffey
Professor Craig Robson
Regulation of the androgen receptor by post-translational modifications2012
Dr Prabhakar Rajan
Caroline Dalgliesh
Pip Carling
Dr Sushma Grellscheid
Dr Kelly Coffey
et al.
Identification of Novel Androgen-Regulated Pathways and mRNA Isoforms through Genome-Wide Exon-Specific Profiling of the LNCaP Transcriptome2011
Dr Luke Gaughan
Dr Jacqueline Stockley
Nan Wang
Dr Stuart McCracken
Dr Kelly Coffey
et al.
Regulation of the androgen receptor by SET9-mediated methylation2011
Dr Kelly Coffey
Professor Craig Robson
Professor Hing Leung
Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer2011
Dr Kelly Coffey
Professor Craig Robson
Professor Hing Leung
NF-κB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells2006
Dr Kelly Coffey
[PhD Thesis] Gene expression analysis in prostate cancer: Effects of Trichostatin A2005
Dr Kelly Coffey
Vincent Gnanapragasam
Professor Craig Robson
Professor Hing Leung
Activation of fibroblast growth factor 8 (FGF8) expression by trichostatin a: A potential role for PI3 kinase2004
Professor Hing Leung
Dr Kelly Coffey
Analysis of Wnt gene expression in prostate cancer: Mutual enhibition by WNT11 and the androgen receptor2004